Fast and Robust Deep Learning for Medical imaging: Segmentation and Registration methods invariant to contrast and resolution
Fast and Robust Deep Learning for Medical imaging: Segmentation and Registration methods invariant to contrast and resolution
批准号:
10733935
负责人:
Adrian Dalca
金额:
$58.5万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-06 至 2027-08-31
关键词:
AddressAgeAnatomyBasic ScienceBayesian ModelingBiologicalClinicalClinical InvestigatorClinical ResearchCollectionComputer softwareDataData SetDevelopmentDiseaseDisease PathwayDrug TargetingImageImage AnalysisKnowledgeLabelLearningLesionLongitudinal StudiesMachine LearningMagnetic Resonance ImagingManualsMapsMedical ImagingMethodsModalityModelingMorphologic artifactsMotionMultimodal ImagingNoiseOutputPhenotypePhysicsPredispositionProcessProtocols documentationQualifyingRaceRecording of previous eventsResearchResearch PersonnelResolutionResourcesScanningScienceScientistSiteSourceSource CodeSpeedStrokeStroke preventionSystemTechniquesTestingTherapeutic InterventionTrainingTreatment EfficacyVariantWhite Matter HyperintensityWorkbrain magnetic resonance imagingcerebrovascularclinical careclinical imagingcohortdeep learningdeep neural networkdesignexperienceheterogenous datahuman diseaseimage registrationimaging Segmentationimprovedinsightlearning strategymultimodalityneural networknovelopen sourceopen source toolsexskillsstroke outcomesuccesstoolvalidation studieswhite matter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Title
Fast and Robust Deep Learning for Medical imaging: Segmentation and Registration methods invariant to con-
trast and resolution.
Summary
Segmentation and registration are critical tasks in a broad range of scientific studies, and have been widely
implemented in imaging analysis frameworks. Unfortunately, most existing tools suffer from two important draw-
backs: they are computationally demanding, and most often impose limiting restrictions on the type of image
data that can be accurately analyzed. While the former drawback has been recently addressed through the use
of deep neural networks that execute rapidly once trained, these systems amplify the latter, which remains a
major restriction. This typically means that tools only yield accurate results on a very limited range of scan types,
most commonly those that they were trained on and are susceptible to repeating bias present in those data. For
segmentation this is particularly burdensome as training frequently requires manually labeled representations for
different types of input data.
The constraint of image type greatly restricts image analysis and its downstream impact in an array of important
domains. For example, in research imaging, it limits multi-site and longitudinal studies that must hold acquisition
protocols constant or attempt to harmonize protocols across different acquisition platforms, and even this process
has limited success when the differences are too extreme (e.g. across field strength). Investigators often need
to adjust, redesign, or retrain the tools for their intended tasks and available images and manual labels, leading
to more barriers to analysis. There is also a wealth of knowledge to be gained from analyzing clinically-sourced
MR images, which could lead to better understanding of the biological underpinnings of many disease processes
and a more precise quantification of the efficacy of therapeutic interventions. However, scans acquired as part
of routine clinical care are often of diverse contrast, significantly lower resolution, and lower quality due to noise
or subject motion. There are few if any publicly available tools that can handle the wide range of acquisition
variability in typical clinical imaging.
We propose to design and distribute machine learning based tools to completely remove these barriers. We will
develop imaging segmentation and registration deep learning methods that retain their accuracy given unpro-
cessed scans of most contrasts or resolution without the need for training data or network fine-tuning to each
data variation. We will build on our recent work in learning-based methods for segmentation, registration, syn-
thesis, and augmentation to leverage the speed of neural networks, the richness of MR physics models, and the
generalizability of probabilistic Bayesian models. We will validate these tools on a large comprehensive multi-site
study incorporating new manual labeling of scans spanning different age, sex, and race . Finally, we will deploy
them to analyze anatomy and white matter lesions in a retrospective stroke cohort. The novel techniques will be
implemented both as standalone open source software as well as part of FreeSurfer analysis package, making
them freely available to thousands of method developers as well as science and clinical researchers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: